通过SENP1介导的SIRT1的SUMOylation通过NF-κB通路影响质瘤的发展
Xin Liu1, Shenglin Zhang1, Yi Dong1
1Department of Oncology, Affiliated Hospital of Chengde Medical University, Chengde, 067000, Hebei, PR China.
Experimental cell research
|October 22, 2023
概括
SUMO特异性蛋白酶1 (SENP1) 在质瘤中表达高,促进瘤生长和预后不佳. 通过向SIRT1/NF-κB通路,抑制SENP1可能为脑瘤提供一种新的治疗策略.
科学领域:
- 神经瘤学神经瘤学
- 分子生物学分子生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 质瘤是成年人脑中的原发性瘤,其特点是潜入性生长和高复发率.
- 表观遗传变化与质瘤的发展和进展有关.
- SUMOylation调节剂越来越多地被认为是它们在癌症中的作用.
研究的目的:
- 为了确定关键的SUMOylation调节器参与质瘤的发病.
- 阐明SENP1影响质瘤进展的分子机制.
- 评估球瘤中准SENP1通路的治疗潜力.
主要方法:
- mRNA 探针杂交以选 SUMOylation 调节器.
- 对质瘤组织中SENP1表达的分析以及与患者预后的相关性.
- 体实验涉及SENP1枯竭 (sh-SENP1) 的实验,以评估对质瘤细胞活性,细胞循环和细胞亡的影响.
- 机制研究研究了SENP1,SIRT1和NF-κB之间的相互作用.
- 救援实验验验证SIRT1和NF-κB.B.的作用.
主要成果:
- SENP1被确定为在质瘤中最显著上调的SUMOylation调节器.
- 在质瘤患者中,SENP1的过度表达与预后不佳相关.
- 减少SENP1减少了质瘤细胞的增殖,诱导了细胞循环停止,并促进了细胞亡.
- 通过脱SUMOylation SENP1 抑制了SIRT1 蛋白表达;SIRT1 通过脱乙烯化抑制了NF-κB活性.
- 降低SIRT1的调节逆转了SENP1耗尽的抗质瘤效应,而NF-κB的降低则逆转了SIRT1上调的益质瘤效应.
结论:
- 通过SIRT1的脱SUMOylation促进质瘤恶性病变,SENP1起着至关重要的作用,后者随后激活NF-κB.
- 针对SIRT1的SENP1-介导的de-SUMOylation代表了质瘤的潜在治疗策略.
- SENP1-SIRT1-NF-κB轴是质瘤进展的关键途径,为治疗提供了新的点.
相关概念视频
02:26NF-κB-dependent Signaling Pathway
7.5K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.5K
01:45Regulation of Nuclear Protein Sorting
2.4K
Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
2.4K
02:23Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
01:22PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
01:20The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K